📣 VC round data is live. Check it out!
- Public Comps
- Asterasys
Asterasys Valuation Multiples
Discover revenue and EBITDA valuation multiples for Asterasys and similar public comparables like Medinice, Ilex Medical, RxSight, Lucid Diagnostics and more.
Asterasys Overview
About Asterasys
Asterasys Co Ltd is a professional healthcare and biomedical corporation based in Korea. It is engaged in the Manufacture of electro-diagnostic and electro-therapeutic apparatuses featuring body composition analyzers such as the InBalance series and HIFU systems such as the Liftera series, it provides total solutions with healthcare, skincare, and IoT-oriented services that can connect with its product portfolio.
Founded
2015
HQ

Employees
N/A
Website
Financials (LTM)
EV
$190M
Valuation Multiples
Start free trialAsterasys Financials
Asterasys reported last 12-month revenue of $30M and EBITDA of $10M.
In the same LTM period, Asterasys generated $24M in gross profit, $10M in EBITDA, and $8M in net income.
Revenue (LTM)
Asterasys P&L
In the most recent fiscal year, Asterasys reported revenue of $25M and EBITDA of $8M.
Asterasys is profitable as of last fiscal year, with gross margin of 78%, EBITDA margin of 33%, and net margin of 24%.
Financial data powered by Morningstar, Inc.
Asterasys Stock Performance
Asterasys has current market cap of $202M, and enterprise value of $190M.
Market Cap Evolution
Asterasys' stock price is $5.37.
Asterasys share price decreased by 5.5% in the last 30 days, and by 35.0% in the last year.
Asterasys has an EPS (earnings per share) of $0.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $190M | $202M | -2.0% | -5.5% | -27.5% | -35.0% | $0.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAsterasys Valuation Multiples
Asterasys trades at 6.3x EV/Revenue multiple, and 18.2x EV/EBITDA.
EV / Revenue (LTM)
Asterasys Financial Valuation Multiples
As of June 3, 2026, Asterasys has market cap of $202M and EV of $190M.
Asterasys has a P/E ratio of 25.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Asterasys Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Asterasys Margins & Growth Rates
Asterasys grew revenue by 44% and EBITDA by 61% in the last fiscal year.
In the most recent fiscal year, Asterasys reported gross margin of 78%, EBITDA margin of 33%, and net margin of 24%.
Asterasys Margins
Asterasys Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Asterasys Operational KPIs
Asterasys' Rule of 40 is 82% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Asterasys' Rule of X is 150% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Asterasys Competitors
Asterasys competitors include Medinice, Ilex Medical, RxSight, Lucid Diagnostics, TriSalus Life Sciences, Sanara MedTech, Anika Therapeutics, Pro-Dex, Huons Co and Utah Medical.
Most Asterasys public comparables operate across IoT, Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | (111.9x) | - | |||
| 0.4x | - | 3.3x | - | |||
| (0.0x) | (0.0x) | 0.1x | 0.0x | |||
| 44.1x | 35.6x | (3.7x) | (4.0x) | |||
| 4.0x | 3.7x | (11.1x) | (12.2x) | |||
| 2.2x | 2.1x | 13.6x | 13.7x | |||
| 1.6x | 1.5x | 33.0x | 24.0x | |||
| 3.3x | 2.9x | 15.7x | - | |||
This data is available for Pro users. Sign up to see all Asterasys competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Asterasys
| When was Asterasys founded? | Asterasys was founded in 2015. |
| Where is Asterasys headquartered? | Asterasys is headquartered in South Korea. |
| Is Asterasys publicly listed? | Yes, Asterasys is a public company listed on Korea Exchange. |
| What is the stock symbol of Asterasys? | Asterasys trades under 450950 ticker. |
| When did Asterasys go public? | Asterasys went public in 2025. |
| Who are competitors of Asterasys? | Asterasys main competitors include Medinice, Ilex Medical, RxSight, Lucid Diagnostics, TriSalus Life Sciences, Sanara MedTech, Anika Therapeutics, Pro-Dex, Huons Co, Utah Medical. |
| What is the current market cap of Asterasys? | Asterasys' current market cap is $202M. |
| What is the current revenue of Asterasys? | Asterasys' last 12 months revenue is $30M. |
| What is the current revenue growth of Asterasys? | Asterasys revenue growth (NTM/LTM) is 40%. |
| What is the current EV/Revenue multiple of Asterasys? | Current revenue multiple of Asterasys is 6.3x. |
| What is the current EBITDA of Asterasys? | Asterasys' last 12 months EBITDA is $10M. |
| What is Asterasys' EBITDA margin? | Asterasys' last 12 months EBITDA margin is 35%. |
| What is the current EV/EBITDA multiple of Asterasys? | Current EBITDA multiple of Asterasys is 18.2x. |
| What is the current FCF of Asterasys? | Asterasys' last 12 months FCF is $6M. |
| What is Asterasys' FCF margin? | Asterasys' last 12 months FCF margin is 19%. |
| What is the current EV/FCF multiple of Asterasys? | Current FCF multiple of Asterasys is 32.9x. |
| How many companies Asterasys has acquired to date? | Asterasys hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Asterasys has invested to date? | Asterasys hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Asterasys
Lists including Asterasys
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.